Highly resistant malaria parasite infects red blood corpuscles to defend itself against the impact of anti-malarial drugs.
Of the two species of Plasmodium parasites commonly infecting humans, P. vivax grows exclusively in immature red blood cells called reticulocytes. P. falciparum can infect reticulocytes, but it grows primarily in mature red blood cells (called erythrocytes) which make up 99% of red cells in circulation.
Malaria
Malaria is caused by a parasite that enters blood through the bite of an infected mosquito. It is characterized by fever, vomiting, shivering, sweating and other symptoms.
Advertisement
The study shows that the different metabolic states of these human host cells provide different growth conditions for the respective parasites and warn that, as a consequence, drugs that work against one Plasmodium species might fail to be effective against the other.
After their birth in the bone marrow, red blood cells undergo a number of changes to develop into highly specialized oxygen transporters.
They expel their nucleus (with its DNA content) before they are released into the blood as reticulocytes.
![New Mosquito-Targeting Antibody Insecticide Offers Hope of]( "New Mosquito-Targeting Antibody Insecticide Offers Hope of")
Recent progress in halting the spread of malaria has hinged on the use of insecticide-treated bed nets and spraying programs that kill mosquitoes.
As they mature they get rid of many of their other organelles as well, until they are disk-shaped cells full of hemoglobin, a red protein (which gives blood its color) designed to carry oxygen.
To address whether the two classes of host red blood cells offer different resources for parasite survival, and whether these resources could influence anti-malarial drug efficacy, researchers undertook a comprehensive biochemical analysis of the metabolites present in reticulocytes on one hand and in mature erythrocytes on the other.
They found that reticulocytes contain elevated levels of many metabolites that could potentially be scavenged by the invading and growing malaria parasite.
Researchers suggest that the availability of the reticulocyte metabolome might reduce or block the efficacy of anti-malarial drugs that target parasite metabolism.
Furthermore reticulocyte resident P. falciparum may enjoy similar protection, giving rise to the possibility that infections could re-emerge.
The study is published in PLOS Pathogens.
Source: ANI
They expel their nucleus (with its DNA content) before they are released into the blood as reticulocytes.
New Mosquito-Targeting Antibody Insecticide Offers Hope of 'Malaria-Free' Future
Recent progress in halting the spread of malaria has hinged on the use of insecticide-treated bed nets and spraying programs that kill mosquitoes.
Advertisement
As they mature they get rid of many of their other organelles as well, until they are disk-shaped cells full of hemoglobin, a red protein (which gives blood its color) designed to carry oxygen.
To address whether the two classes of host red blood cells offer different resources for parasite survival, and whether these resources could influence anti-malarial drug efficacy, researchers undertook a comprehensive biochemical analysis of the metabolites present in reticulocytes on one hand and in mature erythrocytes on the other.
They found that reticulocytes contain elevated levels of many metabolites that could potentially be scavenged by the invading and growing malaria parasite.
Researchers suggest that the availability of the reticulocyte metabolome might reduce or block the efficacy of anti-malarial drugs that target parasite metabolism.
Furthermore reticulocyte resident P. falciparum may enjoy similar protection, giving rise to the possibility that infections could re-emerge.
The study is published in PLOS Pathogens.
Source: ANI
New Breath Test Detects Malaria Earlier Than Standard Blood Examination Method
Higher levels of four sulphuric compounds are detected in the malaria patients' breath. These are in direct correlation with the severity of the infection.
Advertisement
197 Malaria Cases in Tibetan Settlements in 2014: Tsering Wangchuk, Health MinisterDespite widespread health education on the preventative measures against malaria, a large number of new cases are reported every year in Tibetan settlements. | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
A new study explored the link between T immune cells in ill patients and mortality risk.
Limb savage procedure benefits patients with severe vascular disease who are at risk for amputation of their limbs.
Does omega-3 help Alzheimer's patients? A new form of omega-3 helped restore specific markers of eye health in mice bred with aspects of early-onset Alzheimer's disease.
Drugs used to inhibit the physiological responses for allergic reactions lessen osteoarthritis risk, revealed research.
The International Space Station will be used to carry out experiments seeking to improve understanding of incurable child brain tumors and the muscle aging process.